ACE and autonomic neuropathy: In the present era of evidence‐based therapies, for the majority of cardiac amyloid patients, particularly those with restrictive cardiac physiology and autonomic neuropathy, the use of β‐blockers or ACE inhibitors for the treatment of HF is proscribed.